Lebrikizumab Maintains Improvements in the Patient-Oriented Eczema Measure Through 2 Years of Treatment in Patients With Moderate-to-Severe Atopic Dermatitis

Saved in:
Bibliographic Details
Published in:Journal of allergy and clinical immunology 2024-02, Vol.153 (2), p.AB7
Main Authors: Rosmarin, David, Wollenberg, Andreas, Boguniewicz, Mark, Jack, Carolyn, Barbarot, Sebastien, Shi, Vivian, de Bruin-Weller, Marjolein, DeLuca-Carter, Louise, Pierce, Evangeline, Hu, Chaoran, Liu, Chunyuan, Crane, Heidi, Bardolet, Laia, Steinhoff, Martin
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0091-6749
DOI:10.1016/j.jaci.2023.11.045